Early Pregnancy Maternal Vitamin D Concentrations and Risk of Gestational Diabetes Mellitus

Paediatric and Perinatal Epidemiology

Volumn , Issue , 2015, Pages 200-210

  Arnold, Dodie L ^a,b,d   Enquobahrie, Daniel A ^a,b   Qiu, Chungfang ^b   Huang, Jonathan ^a   Grote, Nancy ^c   VanderStoep, Ann ^a   Williams, Michelle A ^a,b,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d LOUISIANA PUBLIC HEALTH INSTITUTE   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

case cohort study; gestational diabetes; pregnancy; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIFEDIOL;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LIQUID CHROMATOGRAPHY; MATERNAL SERUM; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY; RISK FACTOR; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL;

EID: 84984650527     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/ppe.12182     Document Type: Article

References (47)

1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heany RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2011; 96:1911–1930.
2. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. The Journal of Clinical Endocrinology and Metabolism 2011; 96:53–58.
3. De-Regil LM, Palacios C, Ansary A, Kulier R, Peña-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database of Systematic Reviews 2012; (2):CD008873.
4. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2007; 92:2017–2029.
5. Ozfirat Z, Chowdhury TA. Vitamin D deficiency and type 2 diabetes. Postgraduate Medical Journal 2010; 86:18–25.
6. Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 2008; 10:185–197.
7. Watanabe RM, Black MH, Xiang AH, Allayee H, Lawrence JM, Buchanan TA. Genetics of gestational diabetes mellitus and type 2 diabetes. Diabetes Care 2007; 30:134–140.
8. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2001; 86:989–993.
9. Zhang C, Qui C, Hu FB, David RM, Van Dam RM, Bralley M, et al. Maternal plasma 25-Hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS ONE 2008; 3:e3753.
10. Lacroix M, Battista MC, Doyon M, Houde G, Menard J, Ardilouze JL, et al. Lower vitamin D levels at first trimester are associated with higher risk of developing gestational diabetes mellitus. Acta Diabetologica 2014; 51:609–616.
11. McManus R, Summers K, de Vrijer B, Cohen N, Thompson A, Giroux I. Maternal, umbilical arterial and umbilical venous 25-hydroxyvitamin D and adipoctyokine concentrations in pregnancies with and without gestational diabetes. Clinical Endocrinology 2014; 80:635–641.
12. Bener A, Al-Hamaq AO, Saleh NM. Association between vitamin D insufficiency and adverse pregnancy outcome: global comparisons. International Journal of Women's Health 2013; 5:523–531.
13. Baker AM, Haeri S, Camargo CA, Stuebe AM, Boggess KA. First-trimester maternal vitamin D status and risk for gestational diabetes (GDM) a nested case-control study. Diabetes/Metabolism Research and Reviews 2012; 28:164–168.
14. Park S, Yoon H-K, Ryu H-M, Han YJ, Lee SW, Park BK, et al. Maternal vitamin D deficiency in early pregnancy is not associated with gestational diabetes mellitus development or pregnancy outcomes in Korean pregnant women in a prospective study. Journal of Nutritional Science and Vitaminology 2014; 60:269–275.
15. Schneuer FJ, Roberts CL, Gulbert C, Simpson JM, Algert CS, Khambalia AZ, et al. Effects of maternal serum 25-hydroxyvitamin D concentations in the first trimester on subsequent pregnancy outcomes in an Australian population. The American Journal of Clinical Nutrition 2014; 99:287–295.
16. Whitelaw DC, Scally AJ, Tuffnell DJ, Davies TJ, Fraser WD, Bhopal RS, et al. Associations of circulating calcium and 25-hydroxyvitamin D with glucose metabolism in pregnancy: a cross-sectional study in European and South Asian women. The Journal of Clinical Endocrinology and Metabolism 2014; 99:938–946.
17. Zhou J, Su L, Liu M, Liu Y, Cao X, Wang Z, et al. Associations between 25-hydroxyvitamin D levels and pregnancy outcomes: a prospective observational study in southern China. European Journal of Clinical Nutrition 2014; 68:925–930.
18. Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ (Clinical Research Ed.) 2013; 346:f1169.
19. Wei S-Q, Qi H-P, Luo Z-C, Fraser WD. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. The Journal of Maternal-fetal and Neonatal Medicine 2013; 26:889–899.
20. Poel YH, Hummel P, Lips P, Stam F, Van Der Ploeg T, Simsek S, et al. and gestational diabetes: a systematic review and meta-analysis. European Journal of Internal Medicine 2012; 23:465–469.
21. LeBlanc ES, Rizzo JH, Pedula KL, Ensrud KE, Cauley J, Hochberg M, et al. Associations between 25-hydroxyvitamin D and weight gain in elderly women. Journal of Women's Health 2012; 21:1066–1073.
22. Zhang C, Williams MA, Sorensen TK, King IB, Kestin MM, Thompson ML, et al. Maternal plasma ascorbic Acid (vitamin C) and risk of gestational diabetes mellitus. Epidemiology (Cambridge, Mass.) 2004; 15:597–604.
23. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004; 27:S88–S90.
24. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986; 73:1–11.
25. Kass HP, Gold EB. Modern epidemiologic study designs. In: Handbook of Epidemiology. Editors: Ahrens W, Pigeot I. Berlin Heidelberg: Springer-Verlag, 2005; pp. 321–344.
26. Chevrier C, Limon G, Monfort C, Rouget F, Garlantezec R, Petit C, et al. Urinary biomarkers of perenatal atrazine exposure and adverse birth outcomes in the PELAGIE birth cohort. Envrionmental Health Perspectives 2011; 119:1034–1041.
27. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007; 357:266–281.
28. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. American Journal of Epidemiology 1993; 138:923–936.
29. Greenland S, Rothman KJ. Introduction to stratified analysis. In: Modern Epidemiology, 3rd edn. Editors: Rothman KJ, Greenland S, Lash TL. Philadelphia, PA: Lippincott Williams & Wilkins, 2008; pp. 258–302.
30. Vanderweele TJ, Vansteelandt S. Odds ratios for mediation analysis for a dichotomous outcome. American Journal of Epidemiology 2010; 172:1339–1348.
31. Dempsey JC, Sorensen TK, Williams MA, Lee IM, Miller RS, Dashow EE, et al. Prospective study of gestational diabetes mellitus risk in relation to maternal recreational physical activity before and during pregnancy. American Journal of Epidemiology 2004; 159:663–670.
32. Newman SC. Causal analysis of case-control data. Epidemiologic Perspectives and Innovations 2006; 3:2.
33. VanderWeele TJ, Vansteelandt S. A weighting approach to causal effects and additive interaction in case-control studies: marginal structural linear odds models. American Journal of Epidemiology 2011; 174:1197–1203.
34. Horst RL, Reinhardt TA, Reddy S. Vitamin D metabolism. In: Vitamin D. Editors: Feldman D, Pike JW, Glorieux FH. San Diego, CA: Elsevier Academic Press, 2005; pp. 15–36.
35. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. The American Journal of Clinical Nutrition 1998; 68:854–858.
36. Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. Journal of Clinical Endocrinology and Metabolism 2004; 89:5387–5391.
37. Houghton LA, Viet R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. American Journal of Clinical Nutrition 2006; 84:694–697.
38. Hollis BW, Wagner CL, Drezner MK, Binkley C. Circulating vitamin D3 and 25-hydroxyvitamin D in humans: an important tool to define adequate nutritional vitamin D status. The Journal of Steroid Biochemistry and Molecular Biology 2007; 103:631–634.
39. Holmberg I, Berlin T, Ewerth S, Björkhem I. 25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D2 and D3. Scandinavian Journal of Clinical and Laboratory Investigation 1986; 46:785–790.
40. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209:823–825.
41. Sooy K, Schermerhorn T, Noda M, Surana M, Rhoten WB, Meyer M, et al. Calbindin-D(28k) controls [Ca(2+)](i) and insulin release. Evidence obtained from calbindin-d(28k) knockout mice and beta cell lines. The Journal of Biological Chemistry 1999; 274:34343–34349.
42. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. American Journal of Clinical Nutrition 2004; 79:820–825.
43. Tai K, Need AG, Horowitz M, Chapman IM, Vitamin D. glucose, insulin, and insulin sensitivity. Nutrition (Burbank, Los Angeles County, Calif.) 2008; 24:279–285.
44. Alvarez JA, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. International Journal of Endocrinology 2010; 2010:351385.
45. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53:693–700.
46. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 2001; 286:327–334.
47. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003; 52:1799–1805.